Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Extensive-stage Small-cell Lung Cancer
Clinical trial register · Spain

Extensive-stage Small-cell Lung Cancer Trials in Spain, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5882 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:19 UTC
5882
Studies in scope
all four open statuses
3093
Recruiting now
open to new participants
1126
Lead sponsors
across recruiting studies
Top sites
Barcelona 10 Madrid 9 Málaga 7 Seville 6 Valencia 5
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Extensive-stage Small-cell Lung Cancer trials in Spain

13 of 5882 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
BeOne Medicines
Observational
440
Córdoba, Jaén, Lugo, Segovia, Valencia
2026-06-05
Active, closed
Amgen
Phase 3
350
Málaga, Barcelona, Majadahonda, Valencia, Madrid
2025-08-18
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
Novartis Pharmaceuticals
Phase 1/2
280
Barcelona
2025-04-03
Recruiting
BioNTech SE
Phase 3
621
Badajoz, Barcelona, Castellon, León, Madrid, Málaga, Seville, Torrejón de Ardoz
2025-02-03
Recruiting
Amgen
Phase 1
220
Málaga, Barcelona, Valencia, Madrid
2024-10-07
Recruiting
Daiichi Sankyo
Phase 1/2
123
Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Vigo
2024-07-22
Active, closed
Amgen
Phase 3
563
Málaga, Seville, Barcelona, L'Hospitalet de Llobregat, Pamplona, Valencia, Madrid
2024-06-05
Active, closed
Pharmacosmos A/S
Phase 4
302
Seville
2023-10-13
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Badajoz, Las Palmas de Gran Canaria, Majadahonda
2022-10-27
Active, closed
Amgen
Phase 1
184
Badalona, Barcelona, Madrid
2022-08-24
Active, closed
Novartis Pharmaceuticals
Phase 1/2
55
Barcelona, Madrid, Málaga
2022-07-13
Active, closed
Daiichi Sankyo
Phase 2
187
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville
2022-03-09
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-spain/condition/extensive-stage-small-cell-lung-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,882 studies in total at the last sync on 10 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies listing the condition Extensive-stage Small-cell Lung Cancer.

How many Extensive-stage Small-cell Lung Cancer trials are recruiting in Spain?

7 of the 13 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Extensive-stage Small-cell Lung Cancer), 13 studies
PhaseStudiesRecruitingShare
Phase 34230.8%
Phase 1/23223.1%
Phase 12115.4%
Not applicable117.7%
Observational117.7%
Phase 2107.7%
Phase 4107.7%

Most active sponsors

Lead sponsors with the most studies (Extensive-stage Small-cell Lung Cancer)
Lead sponsorStudiesRecruiting
Amgen41
Daiichi Sankyo21
Novartis Pharmaceuticals21
BeOne Medicines11
BioNTech SE11
Bristol-Myers Squibb11
European Organisation for Research and Treatment of Cancer - EORTC11
Pharmacosmos A/S10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.